Cellular Delivert Agent-L17E
An innovative tool, developed by Futaki (Kyoto University), for robust and highlyefficient delivery of biomacromolecules (ex. proteins or antibodies) into the cell. L17E peptide works by preferentially rupturing endosomes to dramatically improve the cytosolic release of endosome-trapped biomacromolecules without cell toxicity.
This compound is manufactured and distributed by Peptide Institute, Inc. under the license of Kyoto University.
The delivery mechanism of antibody into cells using L17E
Modifications and/or conjugations will also be available via custom services.
For more information, please visit Peptide Institute website.
- M. Akishiba, T. Takeuchi, Y. Kawaguchi, K. Sakamoto, H. Yu, I. Nakase, T. Nakase, F. Madani, A. Graslund, S. Futaki, Nature Chemistry, 9, 751 (2017). DOI:10.1038/nchem.2779
- WO2016/052442 A1
- Open All
- Close All
For research use or further manufacturing use only. Not for use in diagnostic procedures.
Product content may differ from the actual image due to minor specification changes etc.
If the revision of product standards and packaging standards has been made, there is a case where the actual product specifications and images are different.